Atara Biotherapeutics
ATRA
ATRA
35 hedge funds and large institutions have $19.6M invested in Atara Biotherapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 16 closing their positions.
Holders
35
Holders Change
-13
Holders Change %
-27.08%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
13
Reduced
12
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EC
1
EcoR1 Capital
San Francisco,
California
|
$3.81M |
| 2 |
2
Millennium Management
New York
|
$1.43M |
| 3 |
3
Renaissance Technologies
New York
|
$551K |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$1.66M |
| 5 |
VPC
5
Vestal Point Capital
New York
|
$1.01M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
New York State Common Retirement Fund
Albany,
New York
| – | – | -32 | Closed |
|
52
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
53
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|